Market Tracker

10/18 5:16pm ET

Sinovac Biotech Ltd (NASDAQ:SVA)

7.07
Delayed Data
As of Oct 18
 +0.05 / +0.71%
Today’s Change
4.60
Today|||52-Week Range
7.16
+19.83%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close7.02
Today’s open7.01
Day’s range6.98 - 7.07
Volume33,184
Average volume (3 months)125,180
Market cap$399.5M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)+600.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+6.84%
P/E ratioNM
Price/Sales4.78
Price/Book3.24

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.14+2.67%
AVEOAveo Pharmaceuticals...+0.02+0.66%
ACIUAC Immune Ltd-0.02-0.17%
GLYCGlycoMimetics Inc-0.34-2.96%
Data as of 3:59pm ET, 10/18/2017

Financials

Last reporting dateApril 11, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$67.4M
Annual profit (last year)-$1.1M
Net profit margin-0.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts